DC
DGX icon

Davenport & Co’s Quest Diagnostics DGX Stock Holding History

Davenport & Co’s Portfolio DGX Stock Details DGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-1,688
Closed -$322K – 1260
2025
Q3 		$322K Buy
1,688
+18
+1% +$3.19K ﹤0.01% 1044
2025
Q2 		$300K Buy
1,670
+110
+7% +$19.1K ﹤0.01% 1052
2025
Q1 		$264K Buy
+1,560
New +$256K ﹤0.01% 1047

Other funds holding DGX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Davenport & Co's DGX Position: Q4 2025 in Review

Davenport & Co sold out of Quest Diagnostics (DGX) in Q4 2025, closing a stake of 1,688 shares — an estimated $322K sold.

Davenport & Co first reported a position in DGX in Q1 2025 and held it in 3 quarters. The position peaked at $322K in Q3 2025. 1,050 funds tracked by Wall St. Rank hold DGX as of Q4 2025.

  • Davenport & Co reported no remaining Quest Diagnostics position as of Q4 2025 after selling out during the quarter.
  • Davenport & Co sold 1,688 Quest Diagnostics shares in Q4 2025, an estimated $322K.
  • Davenport & Co first reported a position in Quest Diagnostics in Q1 2025 and held it in 3 quarters.
  • Davenport & Co's Quest Diagnostics position peaked at $322K in Q3 2025.
  • 1,050 funds tracked by Wall St. Rank held Quest Diagnostics as of Q4 2025.

Based on Davenport & Co's 13F filing for Q4 2025, filed 12 Jan 2026.